First Choice Healthcare Solutions (FCHS) Ratios
First Choice Healthcare Solutions Ratios
FCHS's free cash flow for Q2 2026 was $142.98K. For the 2026 fiscal year, FCHS's free cash flow was decreased by $-4.00 and operating cash flow was $142.98K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.00 | 0.00 | 0.01 | 0.06 | 0.10 |
| Quick Ratio | 0.00 | 0.00 | 0.01 | 0.06 | 0.10 |
| Cash Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Solvency Ratio | -0.16 | -0.10 | -0.26 | -0.37 | -0.50 |
| Operating Cash Flow Ratio | -0.01 | -0.05 | -0.24 | -0.16 | -1.05 |
| Short-Term Operating Cash Flow Coverage | -0.02 | -0.07 | -0.35 | -0.30 | -4.97 |
| Net Current Asset Value | $ -43.57M | $ -36.89M | $ -31.34M | $ -25.59M | $ -14.30M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 7.53 | 6.28 | 7.44 | 2.60 | 2.89 |
| Debt-to-Equity Ratio | -0.77 | -0.87 | -0.81 | -0.83 | -0.91 |
| Debt-to-Capital Ratio | -3.36 | -6.87 | -4.40 | -4.87 | -10.58 |
| Long-Term Debt-to-Capital Ratio | -0.08 | -0.01 | -0.05 | -0.07 | -1.85 |
| Financial Leverage Ratio | -0.10 | -0.14 | -0.11 | -0.32 | -0.32 |
| Debt Service Coverage Ratio | -0.07 | -0.02 | -0.09 | -0.42 | -2.35 |
| Interest Coverage Ratio | -0.57 | -0.38 | -0.41 | -1.89 | -6.08 |
| Debt to Market Cap | 288.82 | 144.38 | 214.86 | 28.90 | 5.43 |
| Interest Debt Per Share | 1.07 | 0.96 | 0.88 | 0.63 | 0.36 |
| Net Debt to EBITDA | -13.65 | -80.02 | -10.53 | -2.75 | -1.71 |
| Profitability Margins | |||||
| Gross Profit Margin | -138.46% | 0.00% | 100.00% | 91.71% | -327.33% |
| EBIT Margin | -30585.85% | 0.00% | -7510.42% | -583.26% | -364.70% |
| EBITDA Margin | -30347.39% | 0.00% | -7360.35% | -574.93% | -348.30% |
| Operating Profit Margin | -36340.59% | 0.00% | -8037.35% | -656.22% | -475.97% |
| Pretax Profit Margin | -94719.97% | 0.00% | -27250.29% | -930.22% | -442.92% |
| Net Profit Margin | -96007.31% | 0.00% | -27250.29% | -930.22% | -442.92% |
| Continuous Operations Profit Margin | -96007.31% | 0.00% | -27250.29% | -930.22% | -442.92% |
| Net Income Per EBT | 101.36% | 103.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 260.65% | 289.84% | 339.05% | 141.75% | 93.06% |
| Return on Assets (ROA) | -174.35% | -85.30% | -261.62% | -152.61% | -214.51% |
| Return on Equity (ROE) | 17.85% | 11.85% | 28.64% | 48.73% | 67.77% |
| Return on Capital Employed (ROCE) | 7.29% | 4.48% | 9.72% | 46.57% | 377.94% |
| Return on Invested Capital (ROIC) | 29.46% | 31.26% | 47.41% | 201.77% | 850.96% |
| Return on Tangible Assets | -174.35% | -85.30% | -261.62% | -152.61% | -214.51% |
| Earnings Yield | -6690.78% | -2245.28% | -8563.79% | -2320.90% | -486.83% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.32 | 0.81 | 3.89 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.01 | 1.71 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.01 | 0.22 | 0.66 |
| Asset Turnover | 0.00 | 0.00 | 0.01 | 0.16 | 0.48 |
| Working Capital Turnover Ratio | -0.00 | 0.00 | -0.00 | -0.08 | -0.38 |
| Cash Conversion Cycle | -273120.77 | -91437.86 | 1125.30 | -39847.84 | -119.58 |
| Days of Sales Outstanding | 0.00 | 0.00 | 1125.30 | 449.34 | 93.95 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 273120.77 | 91437.86 | 0.00 | 40297.18 | 213.53 |
| Operating Cycle | 0.00 | 0.00 | 1125.30 | 449.34 | 93.95 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.02 | -0.05 | -0.21 | -0.10 | -0.18 |
| Free Cash Flow Per Share | -0.02 | -0.05 | -0.21 | -0.10 | -0.19 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -17.87 | -81.95 | -41.89 | -47.42 |
| Capital Expenditure Coverage Ratio | 0.00 | -426659.00 | -81.95 | -41.89 | -47.42 |
| Operating Cash Flow Coverage Ratio | -0.02 | -0.06 | -0.29 | -0.20 | -0.58 |
| Operating Cash Flow to Sales Ratio | -74.70 | 0.00 | -226.63 | -3.16 | -3.48 |
| Free Cash Flow Yield | -520.56% | -995.81% | -7209.01% | -807.55% | -390.12% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.02 | -0.04 | -0.01 | -0.04 | -0.21 |
| Price-to-Sales (P/S) Ratio | 14.35 | 0.00 | 3.18 | 0.40 | 0.91 |
| Price-to-Book (P/B) Ratio | -0.00 | -0.01 | -0.00 | -0.02 | -0.14 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.19 | -0.10 | -0.01 | -0.12 | -0.26 |
| Price-to-Operating Cash Flow Ratio | -0.19 | -0.10 | -0.01 | -0.13 | -0.26 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | 0.00 | 0.00 | -0.00 | -0.01 |
| Enterprise Value Multiple | -13.70 | -80.51 | -10.57 | -2.82 | -1.97 |
| Enterprise Value | 30.56M | 28.50M | 23.33M | 17.35M | 11.90M |
| EV to EBITDA | -13.70 | -80.51 | -10.57 | -2.82 | -1.97 |
| EV to Sales | 4157.83 | 0.00 | 777.90 | 16.23 | 6.88 |
| EV to Free Cash Flow | -55.66 | -16.70 | -3.39 | -5.01 | -1.94 |
| EV to Operating Cash Flow | -55.66 | -16.70 | -3.43 | -5.13 | -1.98 |
| Tangible Book Value Per Share | -1.20 | -0.99 | -0.87 | -0.62 | -0.34 |
| Shareholders’ Equity Per Share | -1.20 | -0.99 | -0.87 | -0.62 | -0.34 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | -0.03 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.03 | 0.05 |
| Net Income Per Share | -0.21 | -0.12 | -0.25 | -0.30 | -0.23 |
| Tax Burden | 1.01 | 1.03 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 3.10 | 9.63 | 3.63 | 1.59 | 1.21 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 256.05 | 0.00 | 81.37 | 7.56 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.08 | 0.44 | 0.83 | 0.34 | 0.78 |
Currency in USD
